{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:39Z","timestamp":1788583659628,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019693","name":"UFFS","doi-asserted-by":"publisher","award":["275\/GR\/UFFS\/2023"],"award-info":[{"award-number":["275\/GR\/UFFS\/2023"]}],"id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019693","name":"UFFS","doi-asserted-by":"publisher","award":["154\/GR\/UFFS\/2024"],"award-info":[{"award-number":["154\/GR\/UFFS\/2024"]}],"id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019693","name":"UFFS","doi-asserted-by":"publisher","award":["73\/GR\/UFFS\/2023"],"award-info":[{"award-number":["73\/GR\/UFFS\/2023"]}],"id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"FAPESC","doi-asserted-by":"publisher","award":["CAP2023091000008"],"award-info":[{"award-number":["CAP2023091000008"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"FAPESC","doi-asserted-by":"publisher","award":["2024TR002211"],"award-info":[{"award-number":["2024TR002211"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.critrevonc.2025.104675","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:10:04Z","timestamp":1740510604000},"page":"104675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy"],"prefix":"10.1016","volume":"209","author":[{"given":"Rafael Zatti","family":"Rossetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Franco Vieira De Oliveira","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia Machado","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.critrevonc.2025.104675_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000513258","article-title":"Localized and locally advanced prostate cancer: treatment options","volume":"99","author":"Achard","year":"2021","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104675_bib2","first-page":"878","article-title":"Emerging roles of P2X receptors in cancer","volume":"22","author":"Adinolfi","year":"2015","journal-title":"Curr.\u00a0Med.\u00a0Chem."},{"key":"10.1016\/j.critrevonc.2025.104675_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2018.05.001","article-title":"Targeting the CD73-adenosine axis in immuno-oncology","volume":"205","author":"Allard","year":"2019","journal-title":"Immunol.\u00a0Lett."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104675_bib4","first-page":"878","article-title":"Emerging roles of P2X receptors in cancer","volume":"22","author":"Amoroso","year":"2015","journal-title":"Curr.\u00a0Med.\u00a0Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104675_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145016","article-title":"Oxidative stress resistance in metastatic prostate cancer: renewal by self-eating","volume":"10","author":"Balvan","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.critrevonc.2025.104675_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00606","article-title":"Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association\/American Society for Radiation Oncology\/Society of Urologic Oncology Guideline","author":"Bekelman","year":"2018","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104675_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14737159.2019.1675515","article-title":"Clinical utility of emerging biomarkers in prostate cancer liquid biopsies","volume":"20","author":"Boerrigter","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2025.104675_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/hq0302.105360","article-title":"Purinergic signaling and vascular cell proliferation and death","volume":"22","author":"Burnstock","year":"2002","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104675_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signaling and cancer","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104675_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091354","article-title":"Purine-metabolising enzymes and apoptosis in cancer","volume":"11","author":"Camici","year":"2019","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104675_bib11","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1111\/jcmm.15500","article-title":"CD73 Acts as a Prognostic Biomarker and PromotesProgression and Immune Escape in Pancreatic Cancer","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.critrevonc.2025.104675_bib12","series-title":"Unidade Max Planck para a Ci\u00eancia dos Pat\u00f3genos","article-title":"CRISPR-Cas9: uma ferramenta para a edi\u00e7\u00e3o de genes","author":"Charpentier","year":"2025"},{"issue":"n. 1","key":"10.1016\/j.critrevonc.2025.104675_bib13","first-page":"1","article-title":"Mitochondrial dysfunction and oxidative stress in prostate cancer","volume":"v. 44","author":"Constanzo-Garvey","year":"2022","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104675_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.critrevonc.2025.104675_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coph.2016.05.001","article-title":"P2 Receptors in cancer progression and metastatic spreading","volume":"29","author":"Di Virgilio","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.critrevonc.2025.104675_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/onc.2016.206","article-title":"Extracellular purines, purinergic receptors, and tumor growth","volume":"36","author":"Di Virgilio","year":"2017","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104675_bib17","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-12-1600","article-title":"Purines, purinergic receptors, and cancer","volume":"72","author":"Di Virgilio","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104675_bib18","doi-asserted-by":"crossref","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"R. purinergic signaling, DAMPs, and inflammation","volume":"318","author":"Di Virgilio","year":"2020","journal-title":"Am. J. Physiol. -Cell Physiol."},{"key":"10.1016\/j.critrevonc.2025.104675_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autneu.2015.04.011","article-title":"Purinergic signaling in the immune system","volume":"191","author":"Di Virgilio","year":"2015","journal-title":"Auton. Neurosci.: Basic Clin."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104675_bib20","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.4049\/jimmunol.172.8.4987","article-title":"A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1\u03b2 processing and release","volume":"172","author":"Elssner","year":"2004","journal-title":"J. Immunol."},{"issue":"S.l","key":"10.1016\/j.critrevonc.2025.104675_bib21","first-page":"1","article-title":"The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer","volume":"v. 14","author":"Gardani","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104675_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11302-018-9642-3","article-title":"Hydrolysis of ATP, ADP, and AMP is increased in the blood plasma of prostate cancer patients","volume":"15","author":"Gardani","year":"2019","journal-title":"Purinergic Signal."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104675_bib23","first-page":"351","article-title":"The role of oxidative stress in prostate cancer","volume":"138","author":"Gupta-elera","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104675_bib24","first-page":"3332","article-title":"Pseudogenes, misannotated genes, and the emergence of novel proteins in cancer: challenges and opportunities","volume":"126","author":"Hayano","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104675_bib25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/cells9112511","article-title":"Inhibiting the P2X4 Receptor Suppresses ProstateCancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target","volume":"9","author":"He","year":"2020","journal-title":"Cells"},{"issue":"n. 626","key":"10.1016\/j.critrevonc.2025.104675_bib26","first-page":"234","article-title":"Oxidative stress and prostate cancer: mitochondrial involvement in tumorigenesis and therapy","volume":"v. 11","author":"Jelic","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104675_bib27","first-page":"431","article-title":"Reactive oxygen species in prostate cancer development and progression","volume":"69","author":"Khandrika","year":"2009","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104675_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11302-011-9228-9","article-title":"Impact of CD39 and purinergic signalling on the growthand metastasis of colorectal cancer","volume":"7","author":"Kunzli","year":"2011","journal-title":"Purinergic Signal."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104675_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1189\/jlb.0802418","article-title":"Alerting and tuning the immune response byextracellular nucleotides","volume":"73","author":"La sala","year":"2003","journal-title":"J.\u00a0Leukoc.\u00a0Biol."},{"key":"10.1016\/j.critrevonc.2025.104675_bib30","first-page":"288","article-title":"Evaluation of Adenosine Deaminase Activity and Its Isoenzymes in Pleural Effusions: Diagnostic and Clinical Implications","volume":"24","author":"Liu","year":"2010","journal-title":"J.\u00a0Clin.\u00a0Lab.\u00a0Anal."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104675_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11302-022-09875-1","article-title":"P2 purinergic receptor dysregulation in urologic disease","volume":"18","author":"Maynard","year":"2022","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.critrevonc.2025.104675_bib32","article-title":"CD39 and CD73 ectonucleotidases in immunity, inflammation, and cancer: pathologic implications and therapeutic targets","volume":"12","author":"Martinelli","year":"2021","journal-title":"Front. Immunol."},{"issue":"n. 8","key":"10.1016\/j.critrevonc.2025.104675_bib33","first-page":"797","article-title":"The role of oxidative stress in prostate cancer","volume":"v. 47","author":"Minelli","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.critrevonc.2025.104675_bib34","first-page":"739","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat.\u00a0Rev.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104675_bib35","first-page":"1321","article-title":"Enzymes involved in purine metabolism-a review of histochemical localization and functional implications","volume":"14","author":"Moriwaki","year":"1999","journal-title":"Histol. Histopathol."},{"issue":"n. 4","key":"10.1016\/j.critrevonc.2025.104675_bib36","first-page":"637","article-title":"Oxidative stress in benign prostatic hyperplasia and prostate cancer","volume":"v. 58","author":"Pace","year":"2010","journal-title":"Eur. Urol."},{"issue":"n. 2","key":"10.1016\/j.critrevonc.2025.104675_bib37","first-page":"141","article-title":"Mitochondrial mutations in prostate cancer: a systematic review","volume":"v. 16","author":"Pande","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"n. 4","key":"10.1016\/j.critrevonc.2025.104675_bib38","first-page":"195","article-title":"Nitrosative and oxidative stress in prostate cancer","volume":"v. 17","author":"Paschos","year":"2013","journal-title":"Prostate Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104675_bib39","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s13577-022-00729-x","article-title":"ATP-gated P2X7 receptor as a potential target for prostate c\u00e2ncer","volume":"35","author":"Qiao","year":"2022","journal-title":"Hum.\u00a0Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104675_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02634137","article-title":"Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types","volume":"28","author":"Rathbone","year":"1992","journal-title":"In Vitro Cellular & Developmental Biology-Animal"},{"issue":"n. 1-2","key":"10.1016\/j.critrevonc.2025.104675_bib41","first-page":"1","article-title":"Prostate cancer and oxidative stress: the role of mitochondrial function","volume":"v. 376","author":"Rebillard","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"482","key":"10.1016\/j.critrevonc.2025.104675_bib42","article-title":"DMB-induced GSDMD-mediated pyroptosis: a novel therapeutic strategy for enhancing anti-tumor immunity","volume":"10","author":"Shentu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"n. 5","key":"10.1016\/j.critrevonc.2025.104675_bib43","first-page":"679","article-title":"Role of oxidative stress in prostate cancer progression","volume":"v. 24","author":"Sikka","year":"2003","journal-title":"J. Androl."},{"issue":"2-3","key":"10.1016\/j.critrevonc.2025.104675_bib44","first-page":"161","article-title":"Tumor-promoting functions of adenosine","volume":"87","author":"Spychala","year":"2000","journal-title":"Clin.\u00a0Pharm.\u00a0Therap."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104675_bib45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/carcin\/bgr101","article-title":"Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1\/2 and Akt and nuclear translocation of NF-\u03baB","volume":"32","author":"Tafani","year":"2011","journal-title":"Carcinog"},{"issue":"n. 1","key":"10.1016\/j.critrevonc.2025.104675_bib46","first-page":"40","article-title":"Role of prostaglandin biosynthesis in inflammation and cancer","volume":"v. 4","author":"Udensi","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"n. 4","key":"10.1016\/j.critrevonc.2025.104675_bib47","first-page":"232","article-title":"Involvement of cyclooxygenase-2 in prostate cancer","volume":"v. 11","author":"Uemura","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104675_bib48","article-title":"Adenosine signaling: Optimal target for gastric cancer immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Front.\u00a0immunol."},{"issue":"n. 7162","key":"10.1016\/j.critrevonc.2025.104675_bib49","article-title":"GPCR-G\u03b113 involvement in mitochondrial function, oxidative stress, and prostate cancer","volume":"v. 25","author":"WU","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104675_bib50","first-page":"1","article-title":"The role of oxidative stress in prostate cancer: molecular mechanisms and therapeutic strategies","volume":"v. 2022","author":"Xia","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104675_fur1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ijlh.12334","article-title":"Elevated serum adenosine deaminase levels in secondaryhemophagocytic lymphohistiocytosis","volume":"37","author":"Chen","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.critrevonc.2025.104675_fur2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-2299(199811\/12)45:3\/4<207::AID-DDR18>3.0.CO;2-N","article-title":"Purinergic P2X7 receptor: a pivotal role in inflammation and immunomodulation","volume":"45","author":"Di Virgilio","year":"1998","journal-title":"Drug Dev. Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:28:14Z","timestamp":1762352894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S1040842825000630"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104675","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104675"}}